Capstan Medical, a developer of robotic-enabled, minimally invasive solutions to address heart valve disease, today announced the appointment of Marshall Mohr to its Board of Directors to further ...
"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.
Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...
By becoming the first health system in the region to offer robotic mitral valve surgery, this minimally invasive approach offers many benefits for patients. In this segment, cardiothoracic ...
Pregnancy acts as a ‘physiologic stress test,’ as it increases cardiac workload by 30–50% to support the foetus,” Dr Bhate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback